Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Partnership

15 Feb 2007 09:04

Plant Health Care PLC15 February 2007 15 February 2007 PLANT HEALTH CARE FORMS PARTNERSHIP WITH AMERICAN SOYBEAN ASSOCIATION Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc("Plant Health Care") and The American Soybean Association ("ASA") announce the2007 "N-Hibit Partnership" field trail programme that will evaluate PlantHealth Care's N-Hibit Seed Treatment, as a tool to lower Soyabean Cyst Nematode(SCN) and improve soybean plant health, during the 2007 growing season. The ASA represents a significant majority of the US soybean growers who plantedsome 75 million acres of soybeans in the US last year. N-Hibit is a dry material that is not a restricted use product. It is easy toapply, has an excellent safety profile and leaves no residuals in the water,soil or on plants. University field research has shown that N-Hibit reduces SCN eggs significantly.Other replicated and commercial research trails have also shown that N-Hibitincreases root and plant growth and increases soybean yield by about 6.5 percent per acre. The active ingredient in N-Hibit and other Harp-N-Tek products is harpinprotein, which is produced by disease causing bacteria that attack plants.Harp-N-Tek products do not contain pathogens, but cause the plant to respond asthough being attacked. Harpin proteins do not enter the plant. They bind withthe plant's external harpin protein receptors, which are present on seed, aswell as foliage. This turns on the plant's natural self defence and growthsystems. Then the harpin proteins harmlessly disintegrate ASA Vice President, Rob Joslin said: "ASA views this field trial program as anopportunity for its members to maximize soybean yield and profitability, andreduce the threat of SCN damage. We believe soybean growers will want to conducttheir own on-farm trials to determine results with N-Hibit on a commercial scaleunder their own growing conditions and management systems to help document theperformance of this seed treatment." John Brady CEO of Plant Health Care said: "We are delighted to be working withthe ASA on the Field Trail Programme for N-Hibit, as it will show soybeangrowers across the US that this product is highly effective and can help themincrease yield per acre and hence their profits. This is the best introductionto the soybean industry and as a result of this association we fully expectsignificant penetration into this huge market by 2008/2009". For further information contact: Plant Health Care plcJohn Brady, CEO; phone: +1 603 525 3702E-Mail: jabrady@planthealthcare.com Tavistock ComunicationsJeremy Carey/Matt Ridsdale, phone: +44 20 7920 3150E-Mail: jcarey@tavistock.co.uk, mridsdale@tavistock.co.uk Notes to Editors: About Plant Health Care:Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.